Answer
Patients of reproductive potential must use highly effective contraception during risdiplam treatment and after the last dose for at least 1 month for female patients and 4 months for male patients.
Sources for this answer
- Evrysdi 0.75 mg/mL powder for oral solutionRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 13Document updated
Sources checked